Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intra‑arterial and intravenous use. It enhances X‑ray imaging by increasing attenuation, aiding procedures such as angiography, CT scans and vascular imaging. GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron is an iodinated contrast agent used in radiographic procedures that require enhanced vascular and tissue visualization. - Angiography: improves delineation of blood vessels for diagnostic and interventional procedures. - Computed tomography (CT) imaging: increases contrast between structures, facilitating accurate interpretation. - Vascular imaging: highlights arterial and venous anatomy to support clinical decision‑making.

Iomeron may cause a range of reactions following administration.

Common Side Effects: - Warm sensation or flushing at the injection site - Nausea or vomiting - Mild headache - Metallic taste in the mouth - Transient urticaria or itching - Mild, temporary hypotension

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Acute kidney injury (contrast‑induced nephropathy) - Severe hypotension or cardiovascular collapse - Pulmonary edema or respiratory distress - Cardiac arrhythmias - Neurological events such as seizures

Prior to using Iomeron, several safety measures should be observed. - Assess renal function: evaluate creatinine clearance to reduce nephrotoxicity risk. - Screen for iodine allergy: obtain detailed allergy history and consider pre‑medication if needed. - Monitor vital signs: observe blood pressure and heart rate during and after injection. - Avoid in uncontrolled hyperthyroidism: iodine load may exacerbate thyroid activity. - Use lowest effective dose: tailor volume to imaging requirements and patient size. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iomeron can interact with several medications, requiring careful management.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in renal impairment; consider temporary discontinuation. - NSAIDs or other nephrotoxic drugs: increase potential for contrast‑induced kidney injury. - Aminoglycoside antibiotics: additive nephrotoxic effect. - Iodine‑containing pharmaceuticals (e.g., thyroid hormones): may amplify iodine load.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia signs of an allergic reaction. - Calcium channel blockers: monitor for hypotensive episodes. - Anticoagulants: assess bleeding risk if renal function declines.